• Home
  • Media
  • Sitemap
  • About Us
    • The company
      • Brief Profile
      • Vision
      • Mission 2013
      • Key Milestones
      • Board of Directors
      • Key Management Team
    • Parabolic Drugs in News
    • Media Gallery
  •  Our Business
    • CRAMS
      • Infrastructure
      • Capabilities
      • Our Business Model
      • Why PDL?
      • Contact CRAMS Division
    • APIs
      • Segments
      • Manufacturing Facilities
      • Our Products
      • Accreditations
      • Contact us for APIs
    • R & D
      • R&D Centre, Barwala
      • R&D Lab, Derabassi
      • IPR,QA & QC
  •  Global Presence
    • Market Presence
    • Regulatory Affairs
    • Business Opportunities
      • Contract Research
      • Contract manufacturing
      • Strategic tieups for Global Marketing
  • Human Resources
    • HR at PDL
      • HR Vision
      • HR Goals
    • Work with us
      • Current Openings
      • Upload your CV
  • CSR
    • CSR Initiatives
    • Environmental Concern
    • Health and Safety
  • Investor Relations
    • MD's Address
    • Corporate Governance
    • Latest Financial Results
    • Key Financial Indicators
    • Shareholding Pattern
    • Annual Reports
    • Track PDL's Share
    • Contact IR
  • Contact us

Segments

The Company is engaged in the manufacture of APIs and API intermediates for sales in India and abroad (including regulated markets).

Broadly the company operates into the following segments:

  • - Semi Synthentic Penicillins-Oral and Sterile


  • - Cephalosporins- Oral and Sterile


  • - Non-Antibiotics


  • - High Potent Active Ingredients


 



 

 

 

 


Go Back | Home

 

 




Parabolic Drugs Limited © 2010 | About Us | Contact us | Sitemap |
Privacy Policy